A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence

BACKGROUND: The improvement of survival outcomes and the reduction of toxicities for esophageal squamous cell carcinoma (SCC) are still needed. We conducted a pilot study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for the treatment of esophageal SCC with T4 and/or M1 lymph n...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Xia, Yi, Chen, Yun, Zhang, Junhua, Deng, Jiaying, Zhao, Kuaile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140386/
https://www.ncbi.nlm.nih.gov/pubmed/32268925
http://dx.doi.org/10.1186/s13014-020-01518-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140386/
https://www.ncbi.nlm.nih.gov/pubmed/32268925
http://dx.doi.org/10.1186/s13014-020-01518-2

Ejemplares similares